Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ELVBullishAnalyst Target Updateanalyst

Medium materiality6/10

UBS raises Elevance Health price target to $523 from $460

Oct 22, 2026, 9:30 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The sizeable target increase and remaining upside indicate a bullish analyst signal, tempered by the limited evidentiary weight of one target revision.

AI summary

What happened, with direct paths to the underlying reporting

UBS raised its ELV price target by $63 to $523, versus the $439.10 posted price—about 19% implied upside to the new target. The revision is directionally positive but is an analyst forecast, not a guarantee.

UBS raised its ELV target to $523 from $460, about 19% above the posted price.

Key facts

01
Target: $523
02
Posted price: $439.1
03
Analyst firm: UBS

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.